<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Prev Med</journal-id><journal-id journal-id-type="iso-abbrev">Int J Prev Med</journal-id><journal-id journal-id-type="publisher-id">IJPVM</journal-id><journal-title-group><journal-title>International Journal of Preventive Medicine</journal-title></journal-title-group><issn pub-type="ppub">2008-7802</issn><issn pub-type="epub">2008-8213</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28656099</article-id><article-id pub-id-type="pmc">5474907</article-id><article-id pub-id-type="publisher-id">IJPVM-8-43</article-id><article-id pub-id-type="doi">10.4103/ijpvm.IJPVM_257_16</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effects of Synbiotic Food Consumption on Serum Minerals, Liver Enzymes, and Blood Pressure in Patients with Type 2 Diabetes: A Double-blind Randomized Cross-over Controlled Clinical Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Asemi</surname><given-names>Zatollah</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Aarabi</surname><given-names>Mohammad Hossein</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Hajijafari</surname><given-names>Mohammad</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Alizadeh</surname><given-names>Sabihe-Alsadat</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Razzaghi</surname><given-names>Reza</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib><contrib contrib-type="author"><name><surname>Mazoochi</surname><given-names>Majid</given-names></name><xref ref-type="aff" rid="aff4">3</xref></contrib><contrib contrib-type="author"><name><surname>Esmaillzadeh</surname><given-names>Ahmad</given-names></name><xref ref-type="aff" rid="aff5">4</xref><xref ref-type="aff" rid="aff6">5</xref><xref ref-type="aff" rid="aff7">6</xref><xref ref-type="corresp" rid="cor1"/></contrib></contrib-group><aff id="aff1"><italic>Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran</italic></aff><aff id="aff2"><label>1</label><italic>Department of Research and Development of Sekkeh Gaz Company, Isfahan, Iran</italic></aff><aff id="aff3"><label>2</label><italic>Department of Infectious Disease, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran</italic></aff><aff id="aff4"><label>3</label><italic>Department of Cardiology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran</italic></aff><aff id="aff5"><label>4</label><italic>Obesity and Eating Habits Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran, Iran</italic></aff><aff id="aff6"><label>5</label><italic>Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran</italic></aff><aff id="aff7"><label>6</label><italic>Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran</italic></aff><author-notes><corresp id="cor1"><italic><bold>Address for correspondence:</bold> Dr. Ahmad Esmaillzadeh, Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, P.O. Box: 14155-6117, Iran. E-mail: <email xlink:href="esmaillzadeh@hlth.mui.ac.ir">esmaillzadeh@hlth.mui.ac.ir</email></italic></corresp></author-notes><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>01</day><month>6</month><year>2017</year></pub-date><volume>8</volume><elocation-id>43</elocation-id><history><date date-type="received"><day>23</day><month>7</month><year>2016</year></date><date date-type="accepted"><day>15</day><month>3</month><year>2017</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2017 International Journal of Preventive Medicine</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>This research was to examine the effects of synbiotic intake on minerals, liver enzymes, and blood pressure in patients with type 2 diabetes (T2D).</p></sec><sec id="st2"><title>Methods:</title><p>This randomized, cross-over clinical trial was performed among 62 diabetic patients. Persons were randomly assigned to intake either a synbiotic (<italic>n</italic> = 62) or a control food (<italic>n</italic> = 62) for 6 weeks. A 3-week washout period was applied following which persons were crossed over to the alternate intervention arm for an additional 6 weeks. The synbiotic was consisted of <italic>Lactobacillus sporogenes</italic> (1 &#x000d7; 10<sup>7</sup> CFU), 0.04 g inulin (HPX) as prebiotic. Persons were asked to consume the synbiotic and control foods 27 g a day. Blood pressure was measured, and blood samples were taken at baseline and after 6-week intervention to assess calcium, magnesium, iron, alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, and total bilirubin.</p></sec><sec id="st3"><title>Results:</title><p>The consumption of a synbiotic food, compared to the control food, resulted in a significant rise of calcium (0.66 vs. &#x02212;0.14 mg/dL, <italic>P</italic> = 0.03) and iron (5.06 vs. &#x02212;9.98 mg/dL, <italic>P</italic> = 0.03). The decrease of total bilirubin (0.08 vs. &#x02212;0.04 mg/dL; <italic>P</italic> = 0.009) was also seen in the synbiotic group compared with the control group.</p></sec><sec id="st4"><title>Conclusions:</title><p>Overall, synbiotic in T2D patients had beneficial effects on calcium, iron, and total bilirubin concentrations.</p></sec></abstract><kwd-group><kwd><italic>Blood pressure</italic></kwd><kwd><italic>liver enzymes</italic></kwd><kwd><italic>serum minerals</italic></kwd><kwd><italic>synbiotic</italic></kwd><kwd><italic>type 2 diabetes</italic></kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>Metabolic complications in patients with type 2 diabetes (T2D) are associated with changes in serum minerals.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>] Insulin resistance in patients with T2D is also established as factor of elevated levels of liver enzymes, hypertension, dyslipidemia, and atherosclerotic cardiovascular diseases.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref>] Increased activities of liver enzymes including alkaline phosphatase (ALP), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) are considered as early surrogate markers of nonalcoholic fatty liver disease.[<xref rid="ref5" ref-type="bibr">5</xref><xref rid="ref6" ref-type="bibr">6</xref>] Earlier studies reported that the elevated values of these enzymes are related to metabolic syndrome and cardiovascular disease.[<xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref>] Furthermore, high blood pressure is associated with thrombosis in vessels,[<xref rid="ref9" ref-type="bibr">9</xref>] heart failure, aortic aneurysms, and atherosclerosis.[<xref rid="ref10" ref-type="bibr">10</xref>]</p><p>Various strategies for the management of diabetes complications have been suggested including the use of fortified food supplements,[<xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref12" ref-type="bibr">12</xref>] supplementation of micronutrients[<xref rid="ref13" ref-type="bibr">13</xref>] as well as physical activity and weight loss,[<xref rid="ref14" ref-type="bibr">14</xref>] consumption of various medications, including rosiglitazone and metformin[<xref rid="ref15" ref-type="bibr">15</xref>] and incretin-based therapies.[<xref rid="ref16" ref-type="bibr">16</xref>] Recently, few trials have documented that intake of synbiotics might result in increased mineral absorption, metabolism, and bone composition,[<xref rid="ref17" ref-type="bibr">17</xref>] as well as decreased activities of liver enzymes[<xref rid="ref18" ref-type="bibr">18</xref>] and might help controlling blood pressure in animal models and nondiabetic patients.[<xref rid="ref19" ref-type="bibr">19</xref>] Synbiotics are nutritional supplements that are composed of probiotics and prebiotics.[<xref rid="ref20" ref-type="bibr">20</xref>] Pro- and pre-biotics might result in decreased activity of liver enzymes through the maintenance of colonization resistance[<xref rid="ref21" ref-type="bibr">21</xref>] and stimulating growth of beneficial probiotic bacteria in the gut.[<xref rid="ref22" ref-type="bibr">22</xref>] Furthermore, released bioactive peptides[<xref rid="ref23" ref-type="bibr">23</xref>] and changes in the gut microbiota composition by pro- and pre-biotics[<xref rid="ref24" ref-type="bibr">24</xref>] may lead to the beneficial effects on blood pressure.</p><p>The objective of our study was to determine the effects of synbiotic intake on minerals, liver enzymes (ALP, AST, and ALT), and blood pressure in Iranian patients with T2D.</p></sec><sec sec-type="methods" id="sec1-2"><title>Methods</title><sec id="sec2-1"><title>Participants</title><p>This randomized, cross-over clinical trial was carried out in Kashan, Iran, from July 2011 to January 2012. On the basis of sample size formula suggested for randomized clinical trials,[<xref rid="ref25" ref-type="bibr">25</xref>] we considered the Type I error of 5% (&#x003b1; = 0.05) and Type II error of 20% (&#x003b2; = 0.2; power = 80%) and plasma calcium levels as a key variable, and we reached the sample size of 31 persons for each group. Diagnosis of T2D was done based on the criteria of the American Diabetes Association.[<xref rid="ref26" ref-type="bibr">26</xref>] Persons were not included pregnant, using insulin or vitamin supplements, chronic or acute inflammatory disease, and allergies, using probiotic, antibiotics, or glucocorticoids during 8 weeks before intervention. The Ethical Committee of Kashan University of Medical Sciences approved the study and informed written consent was obtained from all persons.</p></sec><sec id="sec2-2"><title>Study design</title><p>Persons were asked to record their dietary intakes for 3 dayS. At the end of run-in period, patients were matched one-by-one according to age, body mass index (BMI), gender, and the dosage and kind of medications. A 3-week washout period was applied following which persons were crossed over to the alternate intervention arm for an additional 6 weeks. A trained nutritionist at diabetes clinic did the randomized allocation sequence and assigned participants to the groups. Compliance with the consumption of foods was monitored through phone interviews. The dietary records were based on 3-day food diaries in each phase; we used Nutritionist IV software (First Databank, San Bruno, CA, USA) modified for Iranian foods. Physical activity was described as metabolic equivalents in hours per day.[<xref rid="ref27" ref-type="bibr">27</xref>]</p></sec><sec id="sec2-3"><title>Synbiotic and control foods</title><p>The synbiotic food (Sekkeh Gaz Company, Isfahan, Iran) consisted of <italic>Lactobacillus sporogenes</italic> (1 &#x000d7; 10<sup>7</sup> CFU), 0.04 g inulin (HPX) with 0.38 g isomalt, 0.36 g sorbitol, and 0.05 g stevia as sweetener per 1 g. Persons were requested to take the synbiotic and control foods three times a day in a 9 g package. Due to existence of limited data about the appropriate dosage of <italic>L. sporogenes</italic> and inulin for patients with T2DM, we used the above-mentioned dosage of <italic>L. sporogenes</italic> and inulin based on a previous study in pregnant women.[<xref rid="ref28" ref-type="bibr">28</xref>]</p></sec><sec id="sec2-4"><title>Assessment of variables</title><p>Anthropometric measurements (Seca, Hamburg, Germany) were assessed at baseline and after the 6-week trial. Fasting blood samples (10 mL) were taken at baseline and after a 6-week trial at Kashan reference laboratory. Serum samples were analyzed to determine calcium, magnesium, iron, ALP, AST, ALT, and total bilirubin values. Serum calcium, magnesium, iron, ALP, AST, ALT, and total bilirubin values were assayed using mentioned kits (Pars Azmun Inc., Tehran, Iran). All inter- and intra-assay coefficient of variations mentioned markers were &#x0003c;5%.</p></sec><sec id="sec2-5"><title>Statistical analysis</title><p>To ensure the normal distribution of variables, Histogram and Kolmogorov&#x02013;Smirnov test were applied. For nonnormally distributed variables, log-transformation was applied. Descriptive statistics (means, standard error of the means, and range) for general characteristics of the study participants were reported. Data on dietary intakes were compared by paired <italic>t</italic>-test. For each dependent variable, we computed the changes from baseline by subsidizing the baseline value from the end-of-trial value. With-in and between-group changes in dependent variables were compared by the use of paired samples <italic>t</italic>-test. We also assessed if the carryover and treatment effects were significant. The carryover effect was tested for by computing the average of the two treatments and comparing the two treatment orders using <italic>t</italic>-test. As we found no evidence of a carryover effect, the participants with the two different orders were combined, and the treatment effect was tested for using the paired <italic>t</italic>-test since each patient had each treatment. <italic>P</italic> &#x0003c; 0.05 was considered as statistically significant. All statistical analyses were done using the Statistical Package for Social Science version 17 (SPSS Inc., Chicago, Illinois, USA).</p></sec></sec><sec sec-type="results" id="sec1-3"><title>Results</title><p>At baseline, we recruited 85 patients; however, 15 subjects were excluded from the study because of not living in Kashan (<italic>n</italic> = 10) and not meeting inclusion criteria (<italic>n</italic> = 5). Then, 70 patients with T2D aged 35&#x02013;70 years were randomly allocated to intake either a synbiotic (<italic>n</italic> = 35) or a control food (<italic>n</italic> = 35) for 6 weeks. Among individuals in the synbiotic and control groups, 4 persons were excluded from the study. We found no significant alterations in weight and BMI at study baseline as well as after intervention between individuals consumed synbiotic food and those in the control groups [<xref ref-type="table" rid="T1">Table 1</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>General characteristics of the study participants<sup>a</sup></p></caption><graphic xlink:href="IJPVM-8-43-g001"/></table-wrap><p>No statistically significant difference was observed between the two groups in terms of dietary intakes of energy, calcium, magnesium, zinc, iron, and phosphorus [<xref ref-type="table" rid="T2">Table 2</xref>]. Within-group differences in dietary intakes were also not significant.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Dietary intakes of study participants at run-in period and throughout the study<sup>a</sup></p></caption><graphic xlink:href="IJPVM-8-43-g002"/></table-wrap><p>Intake of synbiotic food did not significantly affect fasting plasma glucose levels compared with control food (<italic>P</italic> = 0.11). Consumption of synbiotic food, compared to the control food, resulted in a significant increase in calcium (0.66 vs. &#x02212;0.14 mg/dL, <italic>P</italic> = 0.03) and iron (5.06 vs. &#x02212;9.98 mg/dL, <italic>P</italic> = 0.03) [<xref ref-type="table" rid="T3">Table 3</xref>]. Decreased values of total bilirubin (0.08 vs. &#x02212;0.04 mg/dL; <italic>P</italic> = 0.009) were seen after synbiotic intake compared with the control. We did see no significant effect of synbiotic food intake on magnesium, ALP, AST, and ALT values. Despite a significant within-group reduction of systolic blood pressure (SBP) (&#x02212;6.69; <italic>P</italic> &#x0003c; 0.0001, &#x02212;4.62 mmHg; <italic>P</italic> = 0.002, respectively) and diastolic blood pressure (DBPs) (&#x02212;4.77; <italic>P</italic> &#x0003c; 0.0001, &#x02212;3.52 mmHg; <italic>P</italic> = 0.01, respectively), by synbiotic and control foods consumption, the between-group differences were not significant.</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Means&#x000b1;standard deviation of serum minerals, liver enzymes and blood pressure at baseline and after the intervention</p></caption><graphic xlink:href="IJPVM-8-43-g003"/></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p>This cross-over clinical trials revealed that the consumption of a synbiotic food for 6 weeks among patients with T2D resulted in a significant increase in serum calcium and iron concentrations and decreased total bilirubin levels. We did not find any significant effect of synbiotic food intake on serum magnesium, ALP, AST, and ALT levels as well as on SBP and DBP. Patients with T2D are very susceptible to abnormal serum minerals, increased activity of liver enzymes, and elevated blood pressure. Elevated activity of liver enzymes and high blood pressure among patients with T2D would result in several disorders, including the development of insulin resistance, vascular diseases, and stroke.[<xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref29" ref-type="bibr">29</xref><xref rid="ref30" ref-type="bibr">30</xref>]</p><p>The current study showed that synbiotic food intake significantly increased serum calcium and iron levels after 6 weeks among patients with T2D, but it did not affect serum magnesium concentrations. Earlier studies have reported beneficial effects of synbiotics, pro-, and pre-biotics on serum minerals. The majority of these studies were performed in animal models. The findings of our study were concurrent with several studies in animal studies. In a study by Naughton <italic>et al</italic>.[<xref rid="ref25" ref-type="bibr">25</xref>] consumption of synbiotics containing <italic>Lactobacillus</italic> GG, <italic>Bifidobacterium lactis</italic> (Bb12), and oligofructose-enriched inulin for 21 days resulted in the increased levels of plasma calcium in aged rats. A significant increase of serum calcium levels with consumption of a probiotic preparation was also seen in broiler chickens.[<xref rid="ref31" ref-type="bibr">31</xref>] Similar findings were also reported after consumption of <italic>Enterococcus faecium</italic> M74 preparation (2 &#x000d7; 10<sup>9</sup> CFU/g) in broiler chickens.[<xref rid="ref32" ref-type="bibr">32</xref>] Furthermore, the effect of inulin ingestion on mineral absorption have been investigated in both growing and adult animals[<xref rid="ref33" ref-type="bibr">33</xref>] and in humans.[<xref rid="ref34" ref-type="bibr">34</xref>] Few studies have shown no significant effect,[<xref rid="ref35" ref-type="bibr">35</xref>] whereas few found that intake of inulin induced the absorption of calcium[<xref rid="ref36" ref-type="bibr">36</xref><xref rid="ref37" ref-type="bibr">37</xref>] or magnesium.[<xref rid="ref38" ref-type="bibr">38</xref>] Ingestion of 40 g/d of inulin has also led to increased calcium absorption among young men.[<xref rid="ref39" ref-type="bibr">39</xref>] Several mechanisms might explain the favorable effects of synbiotics on increased levels of serum calcium and iron. Consumption of synbiotic might result in absorption of calcium and iron. In addition, the production of short-chain fatty acid (SCFA) by probiotics might improve the bioavailability of these trace elements.[<xref rid="ref40" ref-type="bibr">40</xref>] Furthermore, fermentation of inulin in the gut can increase the SCFA production.[<xref rid="ref41" ref-type="bibr">41</xref>] Increases in SCFA production have been associated with increased absorption of calcium and iron.</p><p>Our findings indicated that taking synbiotic in persons with T2D decreased total bilirubin levels, but it did not affect serum ALP, AST, and ALT levels. In a study by Kirpich <italic>et al</italic>.,[<xref rid="ref42" ref-type="bibr">42</xref>] supplementation with <italic>Bifidobacterium bifidum</italic> (0.9 &#x000d7; 10<sup>8</sup> CFU/g) and <italic>Lactobacillus plantarum</italic> 8PA3 (0.9 &#x000d7; 10<sup>9</sup> CFU/g) for 6 weeks was associated with a significant reduction in serum total bilirubin, ALT, AST, GGT, and lactate dehydrogenase levels in human alcohol-induced liver injury. Treatment with fructooligosaccharides was also resulted in a decreased ALT activity compared to controls in rats.[<xref rid="ref43" ref-type="bibr">43</xref>] However, no significant effects of probiotics (Ecologic 641, containing four <italic>Lactobacillus</italic> and two Bifidobacillus strains) were observed on serum bilirubin, ALP, ALT, AST, GGT, prothrombin, albumin, or bile salts in primary sclerosing cholangitis patients for 3 months.[<xref rid="ref44" ref-type="bibr">44</xref>] Furthermore, consumption of <italic>E. faecium</italic> M74 (2 &#x000d7; 10<sup>9</sup> CFU) in experimental chickens led to a significant rise in serum bilirubin levels after 42 days.[<xref rid="ref32" ref-type="bibr">32</xref>] The exact mechanisms by which synbiotics might affect total bilirubin concentrations are unknown. Earlier studies have suggested the probiotic-inflammation relationship. Segawa <italic>et al</italic>.[<xref rid="ref45" ref-type="bibr">45</xref>] found the inhibition of TNF-&#x003b1; by <italic>Lactobacillus brevis</italic>. Biological membranes[<xref rid="ref46" ref-type="bibr">46</xref>] and decreased insulin sensitivity[<xref rid="ref47" ref-type="bibr">47</xref>] and/or promoting pro-inflammatory cytokines[<xref rid="ref46" ref-type="bibr">46</xref>] might mediate the effects on serum bilirubin levels.</p><p>We did not find any significant effect of the synbiotic food consumption on blood pressure among patients with T2D. In consistent with our findings, no significant effects on blood pressure (systolic and diastolic) were seen with supplementation of <italic>Lactobacillus salivarius</italic> Ls-33 (10 CFU) among obese adolescents after 12 weeks.[<xref rid="ref48" ref-type="bibr">48</xref>] Consumption of milk fermented with <italic>Lactobacillus helveticus</italic> resulted in a significant decrease in SBP and a nonsignificant decrease in DBP compared with placebo among patients with mild hypertension after 4 weeks.[<xref rid="ref49" ref-type="bibr">49</xref>] Furthermore, long-chain inulin, oligofructose, or an oligofructose-enriched inulin did not affect the SBP for 15 weeks.[<xref rid="ref50" ref-type="bibr">50</xref>] However, several other studies have reported the decrease of blood pressure through probiotics.[<xref rid="ref23" ref-type="bibr">23</xref><xref rid="ref51" ref-type="bibr">51</xref>] Supplementation with long-chain inulin and oligofructose-enriched inulin prevented fructose-induced elevated blood pressure in rats after 4 weeks.[<xref rid="ref52" ref-type="bibr">52</xref>] The different findings of our study with other studies may be due to the choice, dosage of bacterial strain and inulin, different participants of the study as well as the intervention time.</p><p>Few limitations should be considered in our study. Duration of intervention was just 6 weeks. Long-term trials might reach much more beneficial effects on dependent variables. In addition, further studies are recommended to assess the effects of synbotics supplementation on the expressed levels of related variables to liver enzymes to explore the plausible mechanism and confirm our findings. In this trial, due to funding limitations, we did not characterize the microbiota and thus cannot establish whether taking synbiotic over 6 weeks changed its composition. However, it would be prudent to do this in future studies with a higher CFU treatment of the chosen probiotics product formulation.</p></sec><sec sec-type="conclusions" id="sec1-5"><title>Conclusions</title><p>Overall, synbiotic intake in T2D patients had beneficial effects on serum calcium, iron, and total bilirubin concentrations after 6 weeks; however, it did not affect serum magnesium concentrations, liver enzymes, and blood pressure.</p><sec id="sec2-6"><title>Financial support and sponsorship</title><p>The present study was supported by a grant from the Vice chancellery for Research, Kashan University of Medical Sciences, Iran.</p></sec><sec id="sec2-7" sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilar</surname><given-names>MV</given-names></name><name><surname>Saavedra</surname><given-names>P</given-names></name><name><surname>Arrieta</surname><given-names>FJ</given-names></name><name><surname>Mateos</surname><given-names>CJ</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>MJ</given-names></name><name><surname>Meseguer</surname><given-names>I</given-names></name><etal/></person-group><article-title>Plasma mineral content in type-2 diabetic patients and their association with the metabolic syndrome</article-title><source>Ann Nutr Metab</source><year>2007</year><volume>51</volume><fpage>402</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17851234</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shakeri</surname><given-names>H</given-names></name><name><surname>Hadaegh</surname><given-names>H</given-names></name><name><surname>Abedi</surname><given-names>F</given-names></name><name><surname>Tajabadi-Ebrahimi</surname><given-names>M</given-names></name><name><surname>Mazroii</surname><given-names>N</given-names></name><name><surname>Ghandi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Consumption of synbiotic bread decreases triacylglycerol and VLDL levels while increasing HDL levels in serum from patients with type-2 diabetes</article-title><source>Lipids</source><year>2014</year><volume>49</volume><fpage>695</fpage><lpage>701</lpage><pub-id pub-id-type="pmid">24706266</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuzhandai velu</surname><given-names>V</given-names></name><name><surname>Jyothirmayi</surname><given-names>B</given-names></name><name><surname>Kumar</surname><given-names>JS</given-names></name></person-group><article-title>Insulin resistance and alanine amino transaminase (ALT) levels in first degree relatives of type 2 diabetes mellitus</article-title><source>Diabetes Metab Syndr</source><year>2011</year><volume>5</volume><fpage>143</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22813567</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>JQ</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Pei</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>YL</given-names></name><name><surname>Chang</surname><given-names>YL</given-names></name><name><surname>Hsu</surname><given-names>CH</given-names></name><etal/></person-group><article-title>Improvement of abnormal liver enzymes after rosiglitazone treatment in Chinese type 2 diabetes</article-title><source>Indian J Pharmacol</source><year>2012</year><volume>44</volume><fpage>372</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">22701249</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Targher</surname><given-names>G</given-names></name><name><surname>Day</surname><given-names>CP</given-names></name><name><surname>Bonora</surname><given-names>E</given-names></name></person-group><article-title>Risk of cardiovascular disease in patients with nonalcoholic fatty liverdisease</article-title><source>N Engl J Med</source><year>2010</year><volume>363</volume><fpage>1341</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">20879883</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>DA</given-names></name><name><surname>Srinivasan</surname><given-names>SR</given-names></name><name><surname>Xu</surname><given-names>JH</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Berenson</surname><given-names>GS</given-names></name></person-group><article-title>Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: The Bogalusa Heart Study</article-title><source>Metabolism</source><year>2007</year><volume>56</volume><fpage>792</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17512312</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nannipieri</surname><given-names>M</given-names></name><name><surname>Gonzales</surname><given-names>C</given-names></name><name><surname>Baldi</surname><given-names>S</given-names></name><name><surname>Posadas</surname><given-names>R</given-names></name><name><surname>Williams</surname><given-names>K</given-names></name><name><surname>Haffner</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Liver enzymes, the metabolic syndrome, and incident diabetes: The Mexico City diabetes study</article-title><source>Diabetes Care</source><year>2005</year><volume>28</volume><fpage>1757</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">15983331</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>QM</given-names></name><name><surname>Srinivasan</surname><given-names>SR</given-names></name><name><surname>Xu</surname><given-names>JH</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Hassig</surname><given-names>S</given-names></name><name><surname>Rice</surname><given-names>J</given-names></name><etal/></person-group><article-title>Elevated liver function enzymes are related to the development of prediabetes and type 2 diabetes in younger adults: The Bogalusa heart study</article-title><source>Diabetes Care</source><year>2011</year><volume>34</volume><fpage>2603</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">21953798</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beckman</surname><given-names>JA</given-names></name><name><surname>Creager</surname><given-names>MA</given-names></name><name><surname>Libby</surname><given-names>P</given-names></name></person-group><article-title>Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management</article-title><source>JAMA</source><year>2002</year><volume>287</volume><fpage>2570</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">12020339</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>DR</given-names></name><name><surname>Kite</surname><given-names>A</given-names></name></person-group><article-title>Management of hypertension in peripheral arterial disease: Does the choice of drugs matter?</article-title><source>Eur J Vasc Endovasc Surg</source><year>2008</year><volume>35</volume><fpage>701</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18375152</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shakur</surname><given-names>YA</given-names></name><name><surname>Garriguet</surname><given-names>D</given-names></name><name><surname>Corey</surname><given-names>P</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>DL</given-names></name></person-group><article-title>Folic acid fortification above mandated levels results in a low prevalence of folate inadequacy among Canadians</article-title><source>Am J Clin Nutr</source><year>2010</year><volume>92</volume><fpage>818</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">20739423</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martini</surname><given-names>LA</given-names></name><name><surname>Catania</surname><given-names>AS</given-names></name><name><surname>Ferreira</surname><given-names>SR</given-names></name></person-group><article-title>Role of vitamins and minerals in prevention and management of type 2 diabetes mellitus</article-title><source>Nutr Rev</source><year>2010</year><volume>68</volume><fpage>341</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">20536779</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Bao</surname><given-names>W</given-names></name><name><surname>Jiang</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name></person-group><article-title>Chromium, selenium, and zinc multimineral enriched yeast supplementation ameliorates diabetes symptom in streptozocin-induced mice</article-title><source>Biol Trace Elem Res</source><year>2012</year><volume>146</volume><fpage>236</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">22081404</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blumenthal</surname><given-names>JA</given-names></name><name><surname>Babyak</surname><given-names>MA</given-names></name><name><surname>Hinderliter</surname><given-names>A</given-names></name><name><surname>Watkins</surname><given-names>LL</given-names></name><name><surname>Craighead</surname><given-names>L</given-names></name><name><surname>Lin</surname><given-names>PH</given-names></name><etal/></person-group><article-title>Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: The ENCORE study</article-title><source>Arch Intern Med</source><year>2010</year><volume>170</volume><fpage>126</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">20101007</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iliadis</surname><given-names>F</given-names></name><name><surname>Kadoglou</surname><given-names>NP</given-names></name><name><surname>Hatzitolios</surname><given-names>A</given-names></name><name><surname>Karamouzis</surname><given-names>M</given-names></name><name><surname>Alevizos</surname><given-names>M</given-names></name><name><surname>Karamitsos</surname><given-names>D</given-names></name></person-group><article-title>Metabolic effects of rosiglitazone and metformin in Greek patients with recently diagnosed type 2 diabetes</article-title><source>In Vivo</source><year>2007</year><volume>21</volume><fpage>1107</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">18210765</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yerram</surname><given-names>P</given-names></name><name><surname>Whaley-Connell</surname><given-names>A</given-names></name></person-group><article-title>Novel role for the incretins in blood pressure regulation</article-title><source>Curr Opin Nephrol Hypertens</source><year>2012</year><volume>21</volume><fpage>463</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">22871675</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scholz-Ahrens</surname><given-names>KE</given-names></name><name><surname>Ade</surname><given-names>P</given-names></name><name><surname>Marten</surname><given-names>B</given-names></name><name><surname>Weber</surname><given-names>P</given-names></name><name><surname>Timm</surname><given-names>W</given-names></name><name><surname>A&#x000e7;il</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure</article-title><source>J Nutr</source><year>2007</year><volume>137</volume><issue>3 Suppl 2</issue><fpage>838S</fpage><lpage>46S</lpage><pub-id pub-id-type="pmid">17311984</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sohail</surname><given-names>MU</given-names></name><name><surname>Rahman</surname><given-names>ZU</given-names></name><name><surname>Ijaz</surname><given-names>A</given-names></name><name><surname>Yousaf</surname><given-names>MS</given-names></name><name><surname>Ashraf</surname><given-names>K</given-names></name><name><surname>Yaqub</surname><given-names>T</given-names></name><etal/></person-group><article-title>Single or combined effects of mannan-oligosaccharides and probiotic supplements on the total oxidants, total antioxidants, enzymatic antioxidants, liver enzymes, and serum trace minerals in cyclic heat-stressed broilers</article-title><source>Poult Sci</source><year>2011</year><volume>90</volume><fpage>2573</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22010243</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hord</surname><given-names>NG</given-names></name></person-group><article-title>Eukaryotic-microbiota crosstalk: Potential mechanisms for health benefits of prebiotics and probiotics</article-title><source>Annu Rev Nutr</source><year>2008</year><volume>28</volume><fpage>215</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">18489258</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Vrese</surname><given-names>M</given-names></name><name><surname>Schrezenmeir</surname><given-names>J</given-names></name></person-group><article-title>Probiotics, prebiotics, and synbiotics</article-title><source>Adv Biochem Eng Biotechnol</source><year>2008</year><volume>111</volume><fpage>1</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">18461293</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>HC</given-names></name><name><surname>Li</surname><given-names>LJ</given-names></name><name><surname>Xu</surname><given-names>KJ</given-names></name><name><surname>Shen</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>YB</given-names></name><name><surname>Sheng</surname><given-names>JF</given-names></name><etal/></person-group><article-title>Protective role of supplement with foreign <italic>Bifidobacterium</italic> and <italic>Lactobacillus</italic> in experimental hepatic ischemia-reperfusion injury</article-title><source>J Gastroenterol Hepatol</source><year>2006</year><volume>21</volume><fpage>647</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">16677148</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashem</surname><given-names>MA</given-names></name><name><surname>Mohamed</surname><given-names>MH</given-names></name></person-group><article-title>Haemato-biochemical and pathological studies on aflatoxicosis and treatment of broiler chicks in Egypt</article-title><source>Vet Ital</source><year>2009</year><volume>45</volume><fpage>323</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">20391383</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donkor</surname><given-names>ON</given-names></name><name><surname>Henriksson</surname><given-names>A</given-names></name><name><surname>Vasiljevic</surname><given-names>T</given-names></name><name><surname>Shah</surname><given-names>N</given-names></name></person-group><article-title>[alpha]-Galactosidase and proteolytic activities of selected probiotic and dairy cultures in fermented soymilk</article-title><source>Food Chem</source><year>2007</year><volume>104</volume><fpage>10</fpage><lpage>20</lpage></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cloetens</surname><given-names>L</given-names></name><name><surname>Ulmius</surname><given-names>M</given-names></name><name><surname>Johansson-Persson</surname><given-names>A</given-names></name><name><surname>Akesson</surname><given-names>B</given-names></name><name><surname>Onning</surname><given-names>G</given-names></name></person-group><article-title>Role of dietary beta-glucans in the prevention of the metabolic syndrome</article-title><source>Nutr Rev</source><year>2012</year><volume>70</volume><fpage>444</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">22835138</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naughton</surname><given-names>V</given-names></name><name><surname>McSorley</surname><given-names>E</given-names></name><name><surname>Naughton</surname><given-names>PJ</given-names></name></person-group><article-title>Changes in calcium status in aged rats fed Lactobacillus GG and <italic>Bifidobacterium lactis</italic> and oligofructose-enriched inulin</article-title><source>Appl Physiol Nutr Metab</source><year>2011</year><volume>36</volume><fpage>161</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">21326391</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><article-title>American Diabetes Association. Diagnosis and classification of diabetes mellitus</article-title><source>Diabetes Care</source><year>2012</year><volume>35</volume><issue>Suppl 1</issue><fpage>S64</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">22187472</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ainsworth</surname><given-names>BE</given-names></name><name><surname>Haskell</surname><given-names>WL</given-names></name><name><surname>Whitt</surname><given-names>MC</given-names></name><name><surname>Irwin</surname><given-names>ML</given-names></name><name><surname>Swartz</surname><given-names>AM</given-names></name><name><surname>Strath</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Compendium of physical activities: An update of activity codes and MET intensities</article-title><source>Med Sci Sports Exerc</source><year>2000</year><volume>32</volume><issue>9 Suppl</issue><fpage>S498</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">10993420</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taghizadeh</surname><given-names>M</given-names></name><name><surname>Hashemi</surname><given-names>T</given-names></name><name><surname>Shakeri</surname><given-names>H</given-names></name><name><surname>Abedi</surname><given-names>F</given-names></name><name><surname>Sabihi</surname><given-names>SS</given-names></name><name><surname>Alizadeh</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Synbiotic food consumption reduces levels of triacylglycerols and VLDL, but not cholesterol, LDL, or HDL in plasma from pregnant women</article-title><source>Lipids</source><year>2014</year><volume>49</volume><fpage>155</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">24271261</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanley</surname><given-names>AJ</given-names></name><name><surname>Wagenknecht</surname><given-names>LE</given-names></name><name><surname>Festa</surname><given-names>A</given-names></name><name><surname>D&#x02019;Agostino</surname><given-names>RB</given-names></name><name><surname>Haffner</surname><given-names>SM</given-names></name></person-group><article-title>Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: The Insulin Resistance Atherosclerosis Study</article-title><source>Diabetes Care</source><year>2007</year><volume>30</volume><fpage>1819</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">17429060</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weyer</surname><given-names>C</given-names></name><name><surname>Tataranni</surname><given-names>PA</given-names></name><name><surname>Bogardus</surname><given-names>C</given-names></name><name><surname>Pratley</surname><given-names>RE</given-names></name></person-group><article-title>Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development</article-title><source>Diabetes Care</source><year>2001</year><volume>24</volume><fpage>89</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">11194248</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capcarova</surname><given-names>M</given-names></name><name><surname>Hascik</surname><given-names>P</given-names></name><name><surname>Kolesarova</surname><given-names>A</given-names></name><name><surname>Kacaniova</surname><given-names>M</given-names></name><name><surname>Mihok</surname><given-names>M</given-names></name><name><surname>Pal</surname><given-names>G</given-names></name></person-group><article-title>The effect of selected microbial strains on internal milieu of broiler chickens after peroral administration</article-title><source>Res Vet Sci</source><year>2011</year><volume>91</volume><fpage>132</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">20723955</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capcarova</surname><given-names>M</given-names></name><name><surname>Weiss</surname><given-names>J</given-names></name><name><surname>Hrncar</surname><given-names>C</given-names></name><name><surname>Kolesarova</surname><given-names>A</given-names></name><name><surname>Pal</surname><given-names>G</given-names></name></person-group><article-title>Effect of <italic>Lactobacillus fermentum</italic> and <italic>Enterococcus faecium</italic> strains on internal milieu, antioxidant status and body weight of broiler chickens</article-title><source>J Anim Physiol Anim Nutr (Berl)</source><year>2010</year><volume>94</volume><fpage>e215</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">20626505</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Younes</surname><given-names>H</given-names></name><name><surname>Coudray</surname><given-names>C</given-names></name><name><surname>Bellanger</surname><given-names>J</given-names></name><name><surname>Demign&#x000e9;</surname><given-names>C</given-names></name><name><surname>Rayssiguier</surname><given-names>Y</given-names></name><name><surname>R&#x000e9;m&#x000e9;sy</surname><given-names>C</given-names></name></person-group><article-title>Effects of two fermentable carbohydrates (inulin and resistant starch) and their combination on calcium and magnesium balance in rats</article-title><source>Br J Nutr</source><year>2001</year><volume>86</volume><fpage>479</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">11591235</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coudray</surname><given-names>C</given-names></name><name><surname>Feillet-Coudray</surname><given-names>C</given-names></name><name><surname>Tressol</surname><given-names>JC</given-names></name><name><surname>Gueux</surname><given-names>E</given-names></name><name><surname>Thien</surname><given-names>S</given-names></name><name><surname>Jaffrelo</surname><given-names>L</given-names></name><etal/></person-group><article-title>Stimulatory effect of inulin on intestinal absorption of calcium and magnesium in rats is modulated by dietary calcium intakes short- and long-term balance studies</article-title><source>Eur J Nutr</source><year>2005</year><volume>44</volume><fpage>293</fpage><lpage>302</lpage><pub-id pub-id-type="pmid">15340751</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f3;pez-Huertas</surname><given-names>E</given-names></name><name><surname>Teucher</surname><given-names>B</given-names></name><name><surname>Boza</surname><given-names>JJ</given-names></name><name><surname>Mart&#x000ed;nez-F&#x000e9;rez</surname><given-names>A</given-names></name><name><surname>Majsak-Newman</surname><given-names>G</given-names></name><name><surname>Bar&#x000f3;</surname><given-names>L</given-names></name><etal/></person-group><article-title>Absorption of calcium from milks enriched with fructo-oligosaccharides, caseinophosphopeptides, tricalcium phosphate, and milk solids</article-title><source>Am J Clin Nutr</source><year>2006</year><volume>83</volume><fpage>310</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16469989</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Heuvel</surname><given-names>EG</given-names></name><name><surname>Schoterman</surname><given-names>MH</given-names></name><name><surname>Muijs</surname><given-names>T</given-names></name></person-group><article-title>Transgalactooligosaccharides stimulate calcium absorption in postmenopausal women</article-title><source>J Nutr</source><year>2000</year><volume>130</volume><fpage>2938</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">11110850</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>IJ</given-names></name><name><surname>Davila</surname><given-names>PM</given-names></name><name><surname>Abrams</surname><given-names>SA</given-names></name></person-group><article-title>Non-digestible oligosaccharides and calcium absorption in girls with adequate calcium intakes</article-title><source>Br J Nutr</source><year>2002</year><volume>87</volume><issue>Suppl 2</issue><fpage>S187</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">12088517</pub-id></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tahiri</surname><given-names>M</given-names></name><name><surname>Tressol</surname><given-names>JC</given-names></name><name><surname>Arnaud</surname><given-names>J</given-names></name><name><surname>Bornet</surname><given-names>F</given-names></name><name><surname>Bouteloup-Demange</surname><given-names>C</given-names></name><name><surname>Feillet-Coudray</surname><given-names>C</given-names></name><etal/></person-group><article-title>Five-week intake of short-chain fructo-oligosaccharides increases intestinal absorption and status of magnesium in postmenopausal women</article-title><source>J Bone Miner Res</source><year>2001</year><volume>16</volume><fpage>2152</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">11697813</pub-id></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coudray</surname><given-names>C</given-names></name><name><surname>Bellanger</surname><given-names>J</given-names></name><name><surname>Castiglia-Delavaud</surname><given-names>C</given-names></name><name><surname>R&#x000e9;m&#x000e9;sy</surname><given-names>C</given-names></name><name><surname>Vermorel</surname><given-names>M</given-names></name><name><surname>Rayssignuier</surname><given-names>Y</given-names></name></person-group><article-title>Effect of soluble or partly soluble dietary fibres supplementation on absorption and balance of calcium, magnesium, iron and zinc in healthy young men</article-title><source>Eur J Clin Nutr</source><year>1997</year><volume>51</volume><fpage>375</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">9192195</pub-id></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>MR</given-names></name><name><surname>Dias</surname><given-names>G</given-names></name><name><surname>Ferreira</surname><given-names>CL</given-names></name><name><surname>Franceschini</surname><given-names>SC</given-names></name><name><surname>Costa</surname><given-names>NM</given-names></name></person-group><article-title>Growth of preschool children was improved when fed an iron-fortified fermented milk beverage supplemented with <italic>Lactobacillus acidophilus</italic></article-title><source>Nutr Res</source><year>2008</year><volume>28</volume><fpage>226</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">19083412</pub-id></element-citation></ref><ref id="ref41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sauer</surname><given-names>J</given-names></name><name><surname>Richter</surname><given-names>KK</given-names></name><name><surname>Pool-Zobel</surname><given-names>BL</given-names></name></person-group><article-title>Products formed during fermentation of the prebiotic inulin with human gut flora enhance expression of biotransformation genes in human primary colon cells</article-title><source>Br J Nutr</source><year>2007</year><volume>97</volume><fpage>928</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">17381985</pub-id></element-citation></ref><ref id="ref42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirpich</surname><given-names>IA</given-names></name><name><surname>Solovieva</surname><given-names>NV</given-names></name><name><surname>Leikhter</surname><given-names>SN</given-names></name><name><surname>Shidakova</surname><given-names>NA</given-names></name><name><surname>Lebedeva</surname><given-names>OV</given-names></name><name><surname>Sidorov</surname><given-names>PI</given-names></name><etal/></person-group><article-title>Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: A pilot study</article-title><source>Alcohol</source><year>2008</year><volume>42</volume><fpage>675</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">19038698</pub-id></element-citation></ref><ref id="ref43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neyrinck</surname><given-names>AM</given-names></name><name><surname>Alexiou</surname><given-names>H</given-names></name><name><surname>Delzenne</surname><given-names>NM</given-names></name></person-group><article-title>Kupffer cell activity is involved in the hepatoprotective effect of dietary oligofructose in rats with endotoxic shock</article-title><source>J Nutr</source><year>2004</year><volume>134</volume><fpage>1124</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15113957</pub-id></element-citation></ref><ref id="ref44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vleggaar</surname><given-names>FP</given-names></name><name><surname>Monkelbaan</surname><given-names>JF</given-names></name><name><surname>van Erpecum</surname><given-names>KJ</given-names></name></person-group><article-title>Probiotics in primary sclerosing cholangitis: A randomized placebo-controlled crossover pilot study</article-title><source>Eur J Gastroenterol Hepatol</source><year>2008</year><volume>20</volume><fpage>688</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">18679073</pub-id></element-citation></ref><ref id="ref45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segawa</surname><given-names>S</given-names></name><name><surname>Wakita</surname><given-names>Y</given-names></name><name><surname>Hirata</surname><given-names>H</given-names></name><name><surname>Watari</surname><given-names>J</given-names></name></person-group><article-title>Oral administration of heat-killed <italic>Lactobacillus brevis</italic> SBC8803 ameliorates alcoholic liver disease in ethanol-containing diet-fed C57BL/6N mice</article-title><source>Int J Food Microbiol</source><year>2008</year><volume>128</volume><fpage>371</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">18976829</pub-id></element-citation></ref><ref id="ref46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larson-Meyer</surname><given-names>DE</given-names></name><name><surname>Newcomer</surname><given-names>BR</given-names></name><name><surname>Heilbronn</surname><given-names>LK</given-names></name><name><surname>Volaufova</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>SR</given-names></name><name><surname>Alfonso</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function</article-title><source>Obesity (Silver Spring)</source><year>2008</year><volume>16</volume><fpage>1355</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">18421281</pub-id></element-citation></ref><ref id="ref47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shulman</surname><given-names>GI</given-names></name></person-group><article-title>Cellular mechanisms of insulin resistance</article-title><source>J Clin Invest</source><year>2000</year><volume>106</volume><fpage>171</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10903330</pub-id></element-citation></ref><ref id="ref48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gobel</surname><given-names>RJ</given-names></name><name><surname>Larsen</surname><given-names>N</given-names></name><name><surname>Jakobsen</surname><given-names>M</given-names></name><name><surname>Molgaard</surname><given-names>C</given-names></name><name><surname>Michaelsen</surname><given-names>KF</given-names></name></person-group><article-title>Probiotics to obese adolescents; RCT examining the effects on inflammation and metabolic syndrome</article-title><source>J Pediatr Gastroenterol Nutr</source><year>2012</year><volume>55</volume><fpage>673</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">22695039</pub-id></element-citation></ref><ref id="ref49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aihara</surname><given-names>K</given-names></name><name><surname>Kajimoto</surname><given-names>O</given-names></name><name><surname>Hirata</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>R</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name></person-group><article-title>Effect of powdered fermented milk with <italic>Lactobacillus helveticus</italic> on subjects with high-normal blood pressure or mild hypertension</article-title><source>J Am Coll Nutr</source><year>2005</year><volume>24</volume><fpage>257</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">16093403</pub-id></element-citation></ref><ref id="ref50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rault-Nania</surname><given-names>MH</given-names></name><name><surname>Gueux</surname><given-names>E</given-names></name><name><surname>Demougeot</surname><given-names>C</given-names></name><name><surname>Demign&#x000e9;</surname><given-names>C</given-names></name><name><surname>Rock</surname><given-names>E</given-names></name><name><surname>Mazur</surname><given-names>A</given-names></name></person-group><article-title>Inulin attenuates atherosclerosis in apolipoprotein E-deficient mice</article-title><source>Br J Nutr</source><year>2006</year><volume>96</volume><fpage>840</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">17092371</pub-id></element-citation></ref><ref id="ref51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korhonen</surname><given-names>H</given-names></name></person-group><article-title>Milk-derived bioactive peptides: From science to applications</article-title><source>J Funct Foods</source><year>2009</year><volume>1</volume><fpage>177</fpage><lpage>87</lpage></element-citation></ref><ref id="ref52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rault-Nania</surname><given-names>MH</given-names></name><name><surname>Demougeot</surname><given-names>C</given-names></name><name><surname>Gueux</surname><given-names>E</given-names></name><name><surname>Berthelot</surname><given-names>A</given-names></name><name><surname>Dzimira</surname><given-names>S</given-names></name><name><surname>Rayssiguier</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Inulin supplementation prevents high fructose diet-induced hypertension in rats</article-title><source>Clin Nutr</source><year>2008</year><volume>27</volume><fpage>276</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">18358572</pub-id></element-citation></ref></ref-list></back></article>